Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Oricula Therapeutics secures intellectual property and funding to prevent hearing loss

April 10, 2014

Amarantus acquires option to license intellectual property for MANF and CDNF

March 10, 2014

Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus

Feb. 25, 2014

Third milestone achieved in GenVec and Novartis collaboration

Feb. 17, 2014

Audion Therapeutics and Lilly to develop hearing loss treatments

Feb. 11, 2014

New potassium channel modulators patented by Autifony Therapeutics

Dec. 16, 2013

Otonomy's OTO-201 reduces treatment failure in subjects undergoing ear tube placement surgery

Aug. 21, 2013

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...